Global NGS-based RNA-seq Market Research Report 2026(Status and Outlook)
Factors such as the advantages of RNA-seq over microarray technology, technological advancements in RNA-seq products, increasing number of RNA-seq grants, increasing number of research activities, and rapid growth in precision medicine are driving the growth of the NGS-based RNA-seq market.The hospitals and clinics segment is expected to register the highest growth due to the growing number of agreements between companies and hospitals for the development of advanced tests and products catering to the specific needs of hospitals and clinics.
The global NGS-based RNA-seq market size was estimated at USD 1944.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 11.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global NGS-based RNA-seq market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global NGS-based RNA-seq market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the NGS-based RNA-seq market.
Global NGS-based RNA-seq Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Illumina
Thermo Fisher Scientific
Pacific Biosciences Of California
Qaigen
F. Hoffmann-La Roche
Agilent Technologies
Oxford Nanopore Technologies
Perkinelmer
Eurofins Scientific
Gatc Biotech
Macrogen
Market Segmentation (by Type)
High-Throughput Sequencing
Third-Generation Sequencing Technology
Market Segmentation (by Application)
Hospitals and Clinics
Biopharma Companies
Government Agencies
Academic and Research Organizations
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the NGS-based RNA-seq Market
Overview of the regional outlook of the NGS-based RNA-seq Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the NGS-based RNA-seq Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of NGS-based RNA-seq, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global NGS-based RNA-seq market size was estimated at USD 1944.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 11.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global NGS-based RNA-seq market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global NGS-based RNA-seq market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the NGS-based RNA-seq market.
Global NGS-based RNA-seq Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Illumina
Thermo Fisher Scientific
Pacific Biosciences Of California
Qaigen
F. Hoffmann-La Roche
Agilent Technologies
Oxford Nanopore Technologies
Perkinelmer
Eurofins Scientific
Gatc Biotech
Macrogen
Market Segmentation (by Type)
High-Throughput Sequencing
Third-Generation Sequencing Technology
Market Segmentation (by Application)
Hospitals and Clinics
Biopharma Companies
Government Agencies
Academic and Research Organizations
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the NGS-based RNA-seq Market
Overview of the regional outlook of the NGS-based RNA-seq Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the NGS-based RNA-seq Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of NGS-based RNA-seq, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of NGS-based RNA-seq
1.2 Key Market Segments
1.2.1 NGS-based RNA-seq Segment by Type
1.2.2 NGS-based RNA-seq Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NGS-BASED RNA-SEQ MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global NGS-based RNA-seq Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global NGS-based RNA-seq Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NGS-BASED RNA-SEQ MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global NGS-based RNA-seq Product Life Cycle
3.3 Global NGS-based RNA-seq Sales by Manufacturers (2020-2025)
3.4 Global NGS-based RNA-seq Revenue Market Share by Manufacturers (2020-2025)
3.5 NGS-based RNA-seq Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global NGS-based RNA-seq Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 NGS-based RNA-seq Market Competitive Situation and Trends
3.8.1 NGS-based RNA-seq Market Concentration Rate
3.8.2 Global 5 and 10 Largest NGS-based RNA-seq Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NGS-BASED RNA-SEQ INDUSTRY CHAIN ANALYSIS
4.1 NGS-based RNA-seq Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NGS-BASED RNA-SEQ MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global NGS-based RNA-seq Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to NGS-based RNA-seq Market
5.7 ESG Ratings of Leading Companies
6 NGS-BASED RNA-SEQ MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global NGS-based RNA-seq Sales Market Share by Type (2020-2025)
6.3 Global NGS-based RNA-seq Market Size by Type (2020-2025)
6.4 Global NGS-based RNA-seq Price by Type (2020-2025)
7 NGS-BASED RNA-SEQ MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global NGS-based RNA-seq Market Sales by Application (2020-2025)
7.3 Global NGS-based RNA-seq Market Size (M USD) by Application (2020-2025)
7.4 Global NGS-based RNA-seq Sales Growth Rate by Application (2020-2025)
8 NGS-BASED RNA-SEQ MARKET SALES BY REGION
8.1 Global NGS-based RNA-seq Sales by Region
8.1.1 Global NGS-based RNA-seq Sales by Region
8.1.2 Global NGS-based RNA-seq Sales Market Share by Region
8.2 Global NGS-based RNA-seq Market Size by Region
8.2.1 Global NGS-based RNA-seq Market Size by Region
8.2.2 Global NGS-based RNA-seq Market Size by Region
8.3 North America
8.3.1 North America NGS-based RNA-seq Sales by Country
8.3.2 North America NGS-based RNA-seq Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe NGS-based RNA-seq Sales by Country
8.4.2 Europe NGS-based RNA-seq Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific NGS-based RNA-seq Sales by Region
8.5.2 Asia Pacific NGS-based RNA-seq Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America NGS-based RNA-seq Sales by Country
8.6.2 South America NGS-based RNA-seq Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa NGS-based RNA-seq Sales by Region
8.7.2 Middle East and Africa NGS-based RNA-seq Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NGS-BASED RNA-SEQ MARKET PRODUCTION BY REGION
9.1 Global Production of NGS-based RNA-seq by Region(2020-2025)
9.2 Global NGS-based RNA-seq Revenue Market Share by Region (2020-2025)
9.3 Global NGS-based RNA-seq Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America NGS-based RNA-seq Production
9.4.1 North America NGS-based RNA-seq Production Growth Rate (2020-2025)
9.4.2 North America NGS-based RNA-seq Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe NGS-based RNA-seq Production
9.5.1 Europe NGS-based RNA-seq Production Growth Rate (2020-2025)
9.5.2 Europe NGS-based RNA-seq Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan NGS-based RNA-seq Production (2020-2025)
9.6.1 Japan NGS-based RNA-seq Production Growth Rate (2020-2025)
9.6.2 Japan NGS-based RNA-seq Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China NGS-based RNA-seq Production (2020-2025)
9.7.1 China NGS-based RNA-seq Production Growth Rate (2020-2025)
9.7.2 China NGS-based RNA-seq Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Illumina
10.1.1 Illumina Basic Information
10.1.2 Illumina NGS-based RNA-seq Product Overview
10.1.3 Illumina NGS-based RNA-seq Product Market Performance
10.1.4 Illumina Business Overview
10.1.5 Illumina SWOT Analysis
10.1.6 Illumina Recent Developments
10.2 Thermo Fisher Scientific
10.2.1 Thermo Fisher Scientific Basic Information
10.2.2 Thermo Fisher Scientific NGS-based RNA-seq Product Overview
10.2.3 Thermo Fisher Scientific NGS-based RNA-seq Product Market Performance
10.2.4 Thermo Fisher Scientific Business Overview
10.2.5 Thermo Fisher Scientific SWOT Analysis
10.2.6 Thermo Fisher Scientific Recent Developments
10.3 Pacific Biosciences Of California
10.3.1 Pacific Biosciences Of California Basic Information
10.3.2 Pacific Biosciences Of California NGS-based RNA-seq Product Overview
10.3.3 Pacific Biosciences Of California NGS-based RNA-seq Product Market Performance
10.3.4 Pacific Biosciences Of California Business Overview
10.3.5 Pacific Biosciences Of California SWOT Analysis
10.3.6 Pacific Biosciences Of California Recent Developments
10.4 Qaigen
10.4.1 Qaigen Basic Information
10.4.2 Qaigen NGS-based RNA-seq Product Overview
10.4.3 Qaigen NGS-based RNA-seq Product Market Performance
10.4.4 Qaigen Business Overview
10.4.5 Qaigen Recent Developments
10.5 F. Hoffmann-La Roche
10.5.1 F. Hoffmann-La Roche Basic Information
10.5.2 F. Hoffmann-La Roche NGS-based RNA-seq Product Overview
10.5.3 F. Hoffmann-La Roche NGS-based RNA-seq Product Market Performance
10.5.4 F. Hoffmann-La Roche Business Overview
10.5.5 F. Hoffmann-La Roche Recent Developments
10.6 Agilent Technologies
10.6.1 Agilent Technologies Basic Information
10.6.2 Agilent Technologies NGS-based RNA-seq Product Overview
10.6.3 Agilent Technologies NGS-based RNA-seq Product Market Performance
10.6.4 Agilent Technologies Business Overview
10.6.5 Agilent Technologies Recent Developments
10.7 Oxford Nanopore Technologies
10.7.1 Oxford Nanopore Technologies Basic Information
10.7.2 Oxford Nanopore Technologies NGS-based RNA-seq Product Overview
10.7.3 Oxford Nanopore Technologies NGS-based RNA-seq Product Market Performance
10.7.4 Oxford Nanopore Technologies Business Overview
10.7.5 Oxford Nanopore Technologies Recent Developments
10.8 Perkinelmer
10.8.1 Perkinelmer Basic Information
10.8.2 Perkinelmer NGS-based RNA-seq Product Overview
10.8.3 Perkinelmer NGS-based RNA-seq Product Market Performance
10.8.4 Perkinelmer Business Overview
10.8.5 Perkinelmer Recent Developments
10.9 Eurofins Scientific
10.9.1 Eurofins Scientific Basic Information
10.9.2 Eurofins Scientific NGS-based RNA-seq Product Overview
10.9.3 Eurofins Scientific NGS-based RNA-seq Product Market Performance
10.9.4 Eurofins Scientific Business Overview
10.9.5 Eurofins Scientific Recent Developments
10.10 Gatc Biotech
10.10.1 Gatc Biotech Basic Information
10.10.2 Gatc Biotech NGS-based RNA-seq Product Overview
10.10.3 Gatc Biotech NGS-based RNA-seq Product Market Performance
10.10.4 Gatc Biotech Business Overview
10.10.5 Gatc Biotech Recent Developments
10.11 Macrogen
10.11.1 Macrogen Basic Information
10.11.2 Macrogen NGS-based RNA-seq Product Overview
10.11.3 Macrogen NGS-based RNA-seq Product Market Performance
10.11.4 Macrogen Business Overview
10.11.5 Macrogen Recent Developments
11 NGS-BASED RNA-SEQ MARKET FORECAST BY REGION
11.1 Global NGS-based RNA-seq Market Size Forecast
11.2 Global NGS-based RNA-seq Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe NGS-based RNA-seq Market Size Forecast by Country
11.2.3 Asia Pacific NGS-based RNA-seq Market Size Forecast by Region
11.2.4 South America NGS-based RNA-seq Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of NGS-based RNA-seq by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global NGS-based RNA-seq Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of NGS-based RNA-seq by Type (2026-2035)
12.1.2 Global NGS-based RNA-seq Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of NGS-based RNA-seq by Type (2026-2035)
12.2 Global NGS-based RNA-seq Market Forecast by Application (2026-2035)
12.2.1 Global NGS-based RNA-seq Sales (K Units) Forecast by Application
12.2.2 Global NGS-based RNA-seq Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of NGS-based RNA-seq
1.2 Key Market Segments
1.2.1 NGS-based RNA-seq Segment by Type
1.2.2 NGS-based RNA-seq Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NGS-BASED RNA-SEQ MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global NGS-based RNA-seq Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global NGS-based RNA-seq Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NGS-BASED RNA-SEQ MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global NGS-based RNA-seq Product Life Cycle
3.3 Global NGS-based RNA-seq Sales by Manufacturers (2020-2025)
3.4 Global NGS-based RNA-seq Revenue Market Share by Manufacturers (2020-2025)
3.5 NGS-based RNA-seq Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global NGS-based RNA-seq Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 NGS-based RNA-seq Market Competitive Situation and Trends
3.8.1 NGS-based RNA-seq Market Concentration Rate
3.8.2 Global 5 and 10 Largest NGS-based RNA-seq Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NGS-BASED RNA-SEQ INDUSTRY CHAIN ANALYSIS
4.1 NGS-based RNA-seq Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NGS-BASED RNA-SEQ MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global NGS-based RNA-seq Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to NGS-based RNA-seq Market
5.7 ESG Ratings of Leading Companies
6 NGS-BASED RNA-SEQ MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global NGS-based RNA-seq Sales Market Share by Type (2020-2025)
6.3 Global NGS-based RNA-seq Market Size by Type (2020-2025)
6.4 Global NGS-based RNA-seq Price by Type (2020-2025)
7 NGS-BASED RNA-SEQ MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global NGS-based RNA-seq Market Sales by Application (2020-2025)
7.3 Global NGS-based RNA-seq Market Size (M USD) by Application (2020-2025)
7.4 Global NGS-based RNA-seq Sales Growth Rate by Application (2020-2025)
8 NGS-BASED RNA-SEQ MARKET SALES BY REGION
8.1 Global NGS-based RNA-seq Sales by Region
8.1.1 Global NGS-based RNA-seq Sales by Region
8.1.2 Global NGS-based RNA-seq Sales Market Share by Region
8.2 Global NGS-based RNA-seq Market Size by Region
8.2.1 Global NGS-based RNA-seq Market Size by Region
8.2.2 Global NGS-based RNA-seq Market Size by Region
8.3 North America
8.3.1 North America NGS-based RNA-seq Sales by Country
8.3.2 North America NGS-based RNA-seq Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe NGS-based RNA-seq Sales by Country
8.4.2 Europe NGS-based RNA-seq Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific NGS-based RNA-seq Sales by Region
8.5.2 Asia Pacific NGS-based RNA-seq Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America NGS-based RNA-seq Sales by Country
8.6.2 South America NGS-based RNA-seq Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa NGS-based RNA-seq Sales by Region
8.7.2 Middle East and Africa NGS-based RNA-seq Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NGS-BASED RNA-SEQ MARKET PRODUCTION BY REGION
9.1 Global Production of NGS-based RNA-seq by Region(2020-2025)
9.2 Global NGS-based RNA-seq Revenue Market Share by Region (2020-2025)
9.3 Global NGS-based RNA-seq Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America NGS-based RNA-seq Production
9.4.1 North America NGS-based RNA-seq Production Growth Rate (2020-2025)
9.4.2 North America NGS-based RNA-seq Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe NGS-based RNA-seq Production
9.5.1 Europe NGS-based RNA-seq Production Growth Rate (2020-2025)
9.5.2 Europe NGS-based RNA-seq Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan NGS-based RNA-seq Production (2020-2025)
9.6.1 Japan NGS-based RNA-seq Production Growth Rate (2020-2025)
9.6.2 Japan NGS-based RNA-seq Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China NGS-based RNA-seq Production (2020-2025)
9.7.1 China NGS-based RNA-seq Production Growth Rate (2020-2025)
9.7.2 China NGS-based RNA-seq Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Illumina
10.1.1 Illumina Basic Information
10.1.2 Illumina NGS-based RNA-seq Product Overview
10.1.3 Illumina NGS-based RNA-seq Product Market Performance
10.1.4 Illumina Business Overview
10.1.5 Illumina SWOT Analysis
10.1.6 Illumina Recent Developments
10.2 Thermo Fisher Scientific
10.2.1 Thermo Fisher Scientific Basic Information
10.2.2 Thermo Fisher Scientific NGS-based RNA-seq Product Overview
10.2.3 Thermo Fisher Scientific NGS-based RNA-seq Product Market Performance
10.2.4 Thermo Fisher Scientific Business Overview
10.2.5 Thermo Fisher Scientific SWOT Analysis
10.2.6 Thermo Fisher Scientific Recent Developments
10.3 Pacific Biosciences Of California
10.3.1 Pacific Biosciences Of California Basic Information
10.3.2 Pacific Biosciences Of California NGS-based RNA-seq Product Overview
10.3.3 Pacific Biosciences Of California NGS-based RNA-seq Product Market Performance
10.3.4 Pacific Biosciences Of California Business Overview
10.3.5 Pacific Biosciences Of California SWOT Analysis
10.3.6 Pacific Biosciences Of California Recent Developments
10.4 Qaigen
10.4.1 Qaigen Basic Information
10.4.2 Qaigen NGS-based RNA-seq Product Overview
10.4.3 Qaigen NGS-based RNA-seq Product Market Performance
10.4.4 Qaigen Business Overview
10.4.5 Qaigen Recent Developments
10.5 F. Hoffmann-La Roche
10.5.1 F. Hoffmann-La Roche Basic Information
10.5.2 F. Hoffmann-La Roche NGS-based RNA-seq Product Overview
10.5.3 F. Hoffmann-La Roche NGS-based RNA-seq Product Market Performance
10.5.4 F. Hoffmann-La Roche Business Overview
10.5.5 F. Hoffmann-La Roche Recent Developments
10.6 Agilent Technologies
10.6.1 Agilent Technologies Basic Information
10.6.2 Agilent Technologies NGS-based RNA-seq Product Overview
10.6.3 Agilent Technologies NGS-based RNA-seq Product Market Performance
10.6.4 Agilent Technologies Business Overview
10.6.5 Agilent Technologies Recent Developments
10.7 Oxford Nanopore Technologies
10.7.1 Oxford Nanopore Technologies Basic Information
10.7.2 Oxford Nanopore Technologies NGS-based RNA-seq Product Overview
10.7.3 Oxford Nanopore Technologies NGS-based RNA-seq Product Market Performance
10.7.4 Oxford Nanopore Technologies Business Overview
10.7.5 Oxford Nanopore Technologies Recent Developments
10.8 Perkinelmer
10.8.1 Perkinelmer Basic Information
10.8.2 Perkinelmer NGS-based RNA-seq Product Overview
10.8.3 Perkinelmer NGS-based RNA-seq Product Market Performance
10.8.4 Perkinelmer Business Overview
10.8.5 Perkinelmer Recent Developments
10.9 Eurofins Scientific
10.9.1 Eurofins Scientific Basic Information
10.9.2 Eurofins Scientific NGS-based RNA-seq Product Overview
10.9.3 Eurofins Scientific NGS-based RNA-seq Product Market Performance
10.9.4 Eurofins Scientific Business Overview
10.9.5 Eurofins Scientific Recent Developments
10.10 Gatc Biotech
10.10.1 Gatc Biotech Basic Information
10.10.2 Gatc Biotech NGS-based RNA-seq Product Overview
10.10.3 Gatc Biotech NGS-based RNA-seq Product Market Performance
10.10.4 Gatc Biotech Business Overview
10.10.5 Gatc Biotech Recent Developments
10.11 Macrogen
10.11.1 Macrogen Basic Information
10.11.2 Macrogen NGS-based RNA-seq Product Overview
10.11.3 Macrogen NGS-based RNA-seq Product Market Performance
10.11.4 Macrogen Business Overview
10.11.5 Macrogen Recent Developments
11 NGS-BASED RNA-SEQ MARKET FORECAST BY REGION
11.1 Global NGS-based RNA-seq Market Size Forecast
11.2 Global NGS-based RNA-seq Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe NGS-based RNA-seq Market Size Forecast by Country
11.2.3 Asia Pacific NGS-based RNA-seq Market Size Forecast by Region
11.2.4 South America NGS-based RNA-seq Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of NGS-based RNA-seq by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global NGS-based RNA-seq Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of NGS-based RNA-seq by Type (2026-2035)
12.1.2 Global NGS-based RNA-seq Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of NGS-based RNA-seq by Type (2026-2035)
12.2 Global NGS-based RNA-seq Market Forecast by Application (2026-2035)
12.2.1 Global NGS-based RNA-seq Sales (K Units) Forecast by Application
12.2.2 Global NGS-based RNA-seq Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global NGS-based RNA-seq Market Size by Type (M USD)
Table 4. Global NGS-based RNA-seq Market Size by Application
Table 5. NGS-based RNA-seq Market Size Comparison by Region (M USD)
Table 6. Global NGS-based RNA-seq Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global NGS-based RNA-seq Sales Market Share by Manufacturers (2020-2025)
Table 8. Global NGS-based RNA-seq Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global NGS-based RNA-seq Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-based RNA-seq as of 2025)
Table 11. Global Market NGS-based RNA-seq Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global NGS-based RNA-seq Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. NGS-based RNA-seq Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global NGS-based RNA-seq Sales by Type (K Units)
Table 27. Global NGS-based RNA-seq Market Size by Type (M USD)
Table 28. Global NGS-based RNA-seq Sales (K Units) by Type (2020-2025)
Table 29. Global NGS-based RNA-seq Sales Market Share by Type (2020-2025)
Table 30. Global NGS-based RNA-seq Market Size (M USD) by Type (2020-2025)
Table 31. Global NGS-based RNA-seq Market Share by Type (2020-2025)
Table 32. Global NGS-based RNA-seq Price (USD/Unit) by Type (2020-2025)
Table 33. Global NGS-based RNA-seq Sales (K Units) by Application
Table 34. Global NGS-based RNA-seq Market Size by Application
Table 35. Global NGS-based RNA-seq Sales by Application (2020-2025) & (K Units)
Table 36. Global NGS-based RNA-seq Sales Market Share by Application (2020-2025)
Table 37. Global NGS-based RNA-seq Market Size by Application (2020-2025) & (M USD)
Table 38. Global NGS-based RNA-seq Market Share by Application (2020-2025)
Table 39. Global NGS-based RNA-seq Sales Growth Rate by Application (2020-2025)
Table 40. Global NGS-based RNA-seq Sales by Region (2020-2025) & (K Units)
Table 41. Global NGS-based RNA-seq Sales Market Share by Region (2020-2025)
Table 42. Global NGS-based RNA-seq Market Size by Region (2020-2025) & (M USD)
Table 43. Global NGS-based RNA-seq Market Size by Region (2020-2025)
Table 44. North America NGS-based RNA-seq Sales by Country (2020-2025) & (K Units)
Table 45. North America NGS-based RNA-seq Market Size by Country (2020-2025) & (M USD)
Table 46. Europe NGS-based RNA-seq Sales by Country (2020-2025) & (K Units)
Table 47. Europe NGS-based RNA-seq Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific NGS-based RNA-seq Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific NGS-based RNA-seq Market Size by Region (2020-2025) & (M USD)
Table 50. South America NGS-based RNA-seq Sales by Country (2020-2025) & (K Units)
Table 51. South America NGS-based RNA-seq Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa NGS-based RNA-seq Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa NGS-based RNA-seq Market Size by Region (2020-2025) & (M USD)
Table 54. Global NGS-based RNA-seq Production (K Units) by Region(2020-2025)
Table 55. Global NGS-based RNA-seq Revenue (US$ Million) by Region (2020-2025)
Table 56. Global NGS-based RNA-seq Revenue Market Share by Region (2020-2025)
Table 57. Global NGS-based RNA-seq Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America NGS-based RNA-seq Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe NGS-based RNA-seq Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan NGS-based RNA-seq Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China NGS-based RNA-seq Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Illumina Basic Information
Table 63. Illumina NGS-based RNA-seq Product Overview
Table 64. Illumina NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Illumina Business Overview
Table 66. Illumina SWOT Analysis
Table 67. Illumina Recent Developments
Table 68. Thermo Fisher Scientific Basic Information
Table 69. Thermo Fisher Scientific NGS-based RNA-seq Product Overview
Table 70. Thermo Fisher Scientific NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Thermo Fisher Scientific Business Overview
Table 72. Thermo Fisher Scientific SWOT Analysis
Table 73. Thermo Fisher Scientific Recent Developments
Table 74. Pacific Biosciences Of California Basic Information
Table 75. Pacific Biosciences Of California NGS-based RNA-seq Product Overview
Table 76. Pacific Biosciences Of California NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Pacific Biosciences Of California Business Overview
Table 78. Pacific Biosciences Of California SWOT Analysis
Table 79. Pacific Biosciences Of California Recent Developments
Table 80. Qaigen Basic Information
Table 81. Qaigen NGS-based RNA-seq Product Overview
Table 82. Qaigen NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Qaigen Business Overview
Table 84. Qaigen Recent Developments
Table 85. F. Hoffmann-La Roche Basic Information
Table 86. F. Hoffmann-La Roche NGS-based RNA-seq Product Overview
Table 87. F. Hoffmann-La Roche NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. F. Hoffmann-La Roche Business Overview
Table 89. F. Hoffmann-La Roche Recent Developments
Table 90. Agilent Technologies Basic Information
Table 91. Agilent Technologies NGS-based RNA-seq Product Overview
Table 92. Agilent Technologies NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Agilent Technologies Business Overview
Table 94. Agilent Technologies Recent Developments
Table 95. Oxford Nanopore Technologies Basic Information
Table 96. Oxford Nanopore Technologies NGS-based RNA-seq Product Overview
Table 97. Oxford Nanopore Technologies NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Oxford Nanopore Technologies Business Overview
Table 99. Oxford Nanopore Technologies Recent Developments
Table 100. Perkinelmer Basic Information
Table 101. Perkinelmer NGS-based RNA-seq Product Overview
Table 102. Perkinelmer NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Perkinelmer Business Overview
Table 104. Perkinelmer Recent Developments
Table 105. Eurofins Scientific Basic Information
Table 106. Eurofins Scientific NGS-based RNA-seq Product Overview
Table 107. Eurofins Scientific NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Eurofins Scientific Business Overview
Table 109. Eurofins Scientific Recent Developments
Table 110. Gatc Biotech Basic Information
Table 111. Gatc Biotech NGS-based RNA-seq Product Overview
Table 112. Gatc Biotech NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Gatc Biotech Business Overview
Table 114. Gatc Biotech Recent Developments
Table 115. Macrogen Basic Information
Table 116. Macrogen NGS-based RNA-seq Product Overview
Table 117. Macrogen NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Macrogen Business Overview
Table 119. Macrogen Recent Developments
Table 120. Global NGS-based RNA-seq Sales Forecast by Region (2026-2035) & (K Units)
Table 121. Global NGS-based RNA-seq Market Size Forecast by Region (2026-2035) & (M USD)
Table 122. North America NGS-based RNA-seq Sales Forecast by Country (2026-2035) & (K Units)
Table 123. North America NGS-based RNA-seq Market Size Forecast by Country (2026-2035) & (M USD)
Table 124. Europe NGS-based RNA-seq Sales Forecast by Country (2026-2035) & (K Units)
Table 125. Europe NGS-based RNA-seq Market Size Forecast by Country (2026-2035) & (M USD)
Table 126. Asia Pacific NGS-based RNA-seq Sales Forecast by Region (2026-2035) & (K Units)
Table 127. Asia Pacific NGS-based RNA-seq Market Size Forecast by Region (2026-2035) & (M USD)
Table 128. South America NGS-based RNA-seq Sales Forecast by Country (2026-2035) & (K Units)
Table 129. South America NGS-based RNA-seq Market Size Forecast by Country (2026-2035) & (M USD)
Table 130. Middle East and Africa NGS-based RNA-seq Sales Forecast by Country (2026-2035) & (Units)
Table 131. Middle East and Africa NGS-based RNA-seq Market Size Forecast by Country (2026-2035) & (M USD)
Table 132. Global NGS-based RNA-seq Sales Forecast by Type (2026-2035) & (K Units)
Table 133. Global NGS-based RNA-seq Market Size Forecast by Type (2026-2035) & (M USD)
Table 134. Global NGS-based RNA-seq Price Forecast by Type (2026-2035) & (USD/Unit)
Table 135. Global NGS-based RNA-seq Sales (K Units) Forecast by Application (2026-2035)
Table 136. Global NGS-based RNA-seq Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global NGS-based RNA-seq Market Size by Type (M USD)
Table 4. Global NGS-based RNA-seq Market Size by Application
Table 5. NGS-based RNA-seq Market Size Comparison by Region (M USD)
Table 6. Global NGS-based RNA-seq Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global NGS-based RNA-seq Sales Market Share by Manufacturers (2020-2025)
Table 8. Global NGS-based RNA-seq Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global NGS-based RNA-seq Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-based RNA-seq as of 2025)
Table 11. Global Market NGS-based RNA-seq Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global NGS-based RNA-seq Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. NGS-based RNA-seq Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global NGS-based RNA-seq Sales by Type (K Units)
Table 27. Global NGS-based RNA-seq Market Size by Type (M USD)
Table 28. Global NGS-based RNA-seq Sales (K Units) by Type (2020-2025)
Table 29. Global NGS-based RNA-seq Sales Market Share by Type (2020-2025)
Table 30. Global NGS-based RNA-seq Market Size (M USD) by Type (2020-2025)
Table 31. Global NGS-based RNA-seq Market Share by Type (2020-2025)
Table 32. Global NGS-based RNA-seq Price (USD/Unit) by Type (2020-2025)
Table 33. Global NGS-based RNA-seq Sales (K Units) by Application
Table 34. Global NGS-based RNA-seq Market Size by Application
Table 35. Global NGS-based RNA-seq Sales by Application (2020-2025) & (K Units)
Table 36. Global NGS-based RNA-seq Sales Market Share by Application (2020-2025)
Table 37. Global NGS-based RNA-seq Market Size by Application (2020-2025) & (M USD)
Table 38. Global NGS-based RNA-seq Market Share by Application (2020-2025)
Table 39. Global NGS-based RNA-seq Sales Growth Rate by Application (2020-2025)
Table 40. Global NGS-based RNA-seq Sales by Region (2020-2025) & (K Units)
Table 41. Global NGS-based RNA-seq Sales Market Share by Region (2020-2025)
Table 42. Global NGS-based RNA-seq Market Size by Region (2020-2025) & (M USD)
Table 43. Global NGS-based RNA-seq Market Size by Region (2020-2025)
Table 44. North America NGS-based RNA-seq Sales by Country (2020-2025) & (K Units)
Table 45. North America NGS-based RNA-seq Market Size by Country (2020-2025) & (M USD)
Table 46. Europe NGS-based RNA-seq Sales by Country (2020-2025) & (K Units)
Table 47. Europe NGS-based RNA-seq Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific NGS-based RNA-seq Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific NGS-based RNA-seq Market Size by Region (2020-2025) & (M USD)
Table 50. South America NGS-based RNA-seq Sales by Country (2020-2025) & (K Units)
Table 51. South America NGS-based RNA-seq Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa NGS-based RNA-seq Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa NGS-based RNA-seq Market Size by Region (2020-2025) & (M USD)
Table 54. Global NGS-based RNA-seq Production (K Units) by Region(2020-2025)
Table 55. Global NGS-based RNA-seq Revenue (US$ Million) by Region (2020-2025)
Table 56. Global NGS-based RNA-seq Revenue Market Share by Region (2020-2025)
Table 57. Global NGS-based RNA-seq Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America NGS-based RNA-seq Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe NGS-based RNA-seq Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan NGS-based RNA-seq Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China NGS-based RNA-seq Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Illumina Basic Information
Table 63. Illumina NGS-based RNA-seq Product Overview
Table 64. Illumina NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Illumina Business Overview
Table 66. Illumina SWOT Analysis
Table 67. Illumina Recent Developments
Table 68. Thermo Fisher Scientific Basic Information
Table 69. Thermo Fisher Scientific NGS-based RNA-seq Product Overview
Table 70. Thermo Fisher Scientific NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Thermo Fisher Scientific Business Overview
Table 72. Thermo Fisher Scientific SWOT Analysis
Table 73. Thermo Fisher Scientific Recent Developments
Table 74. Pacific Biosciences Of California Basic Information
Table 75. Pacific Biosciences Of California NGS-based RNA-seq Product Overview
Table 76. Pacific Biosciences Of California NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Pacific Biosciences Of California Business Overview
Table 78. Pacific Biosciences Of California SWOT Analysis
Table 79. Pacific Biosciences Of California Recent Developments
Table 80. Qaigen Basic Information
Table 81. Qaigen NGS-based RNA-seq Product Overview
Table 82. Qaigen NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Qaigen Business Overview
Table 84. Qaigen Recent Developments
Table 85. F. Hoffmann-La Roche Basic Information
Table 86. F. Hoffmann-La Roche NGS-based RNA-seq Product Overview
Table 87. F. Hoffmann-La Roche NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. F. Hoffmann-La Roche Business Overview
Table 89. F. Hoffmann-La Roche Recent Developments
Table 90. Agilent Technologies Basic Information
Table 91. Agilent Technologies NGS-based RNA-seq Product Overview
Table 92. Agilent Technologies NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Agilent Technologies Business Overview
Table 94. Agilent Technologies Recent Developments
Table 95. Oxford Nanopore Technologies Basic Information
Table 96. Oxford Nanopore Technologies NGS-based RNA-seq Product Overview
Table 97. Oxford Nanopore Technologies NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Oxford Nanopore Technologies Business Overview
Table 99. Oxford Nanopore Technologies Recent Developments
Table 100. Perkinelmer Basic Information
Table 101. Perkinelmer NGS-based RNA-seq Product Overview
Table 102. Perkinelmer NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Perkinelmer Business Overview
Table 104. Perkinelmer Recent Developments
Table 105. Eurofins Scientific Basic Information
Table 106. Eurofins Scientific NGS-based RNA-seq Product Overview
Table 107. Eurofins Scientific NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Eurofins Scientific Business Overview
Table 109. Eurofins Scientific Recent Developments
Table 110. Gatc Biotech Basic Information
Table 111. Gatc Biotech NGS-based RNA-seq Product Overview
Table 112. Gatc Biotech NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Gatc Biotech Business Overview
Table 114. Gatc Biotech Recent Developments
Table 115. Macrogen Basic Information
Table 116. Macrogen NGS-based RNA-seq Product Overview
Table 117. Macrogen NGS-based RNA-seq Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Macrogen Business Overview
Table 119. Macrogen Recent Developments
Table 120. Global NGS-based RNA-seq Sales Forecast by Region (2026-2035) & (K Units)
Table 121. Global NGS-based RNA-seq Market Size Forecast by Region (2026-2035) & (M USD)
Table 122. North America NGS-based RNA-seq Sales Forecast by Country (2026-2035) & (K Units)
Table 123. North America NGS-based RNA-seq Market Size Forecast by Country (2026-2035) & (M USD)
Table 124. Europe NGS-based RNA-seq Sales Forecast by Country (2026-2035) & (K Units)
Table 125. Europe NGS-based RNA-seq Market Size Forecast by Country (2026-2035) & (M USD)
Table 126. Asia Pacific NGS-based RNA-seq Sales Forecast by Region (2026-2035) & (K Units)
Table 127. Asia Pacific NGS-based RNA-seq Market Size Forecast by Region (2026-2035) & (M USD)
Table 128. South America NGS-based RNA-seq Sales Forecast by Country (2026-2035) & (K Units)
Table 129. South America NGS-based RNA-seq Market Size Forecast by Country (2026-2035) & (M USD)
Table 130. Middle East and Africa NGS-based RNA-seq Sales Forecast by Country (2026-2035) & (Units)
Table 131. Middle East and Africa NGS-based RNA-seq Market Size Forecast by Country (2026-2035) & (M USD)
Table 132. Global NGS-based RNA-seq Sales Forecast by Type (2026-2035) & (K Units)
Table 133. Global NGS-based RNA-seq Market Size Forecast by Type (2026-2035) & (M USD)
Table 134. Global NGS-based RNA-seq Price Forecast by Type (2026-2035) & (USD/Unit)
Table 135. Global NGS-based RNA-seq Sales (K Units) Forecast by Application (2026-2035)
Table 136. Global NGS-based RNA-seq Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of NGS-based RNA-seq
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global NGS-based RNA-seq Market Size (M USD), 2025-2035
Figure 5. Global NGS-based RNA-seq Market Size (M USD) (2020-2035)
Figure 6. Global NGS-based RNA-seq Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. NGS-based RNA-seq Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global NGS-based RNA-seq Product Life Cycle
Figure 13. NGS-based RNA-seq Sales Share by Manufacturers in 2025
Figure 14. Global NGS-based RNA-seq Revenue Share by Manufacturers in 2025
Figure 15. NGS-based RNA-seq Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market NGS-based RNA-seq Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by NGS-based RNA-seq Revenue in 2025
Figure 18. Industry Chain Map of NGS-based RNA-seq
Figure 19. Global NGS-based RNA-seq Market PEST Analysis
Figure 20. Global NGS-based RNA-seq Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global NGS-based RNA-seq Market Share by Type
Figure 27. Sales Market Share of NGS-based RNA-seq by Type (2020-2025)
Figure 28. Sales Market Share of NGS-based RNA-seq by Type in 2025
Figure 29. Market Share of NGS-based RNA-seq by Type (2020-2025)
Figure 30. Market Share of NGS-based RNA-seq by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global NGS-based RNA-seq Market Share by Application
Figure 33. Global NGS-based RNA-seq Sales Market Share by Application (2020-2025)
Figure 34. Global NGS-based RNA-seq Sales Market Share by Application in 2025
Figure 35. Global NGS-based RNA-seq Market Share by Application (2020-2025)
Figure 36. Global NGS-based RNA-seq Market Share by Application in 2025
Figure 37. Global NGS-based RNA-seq Sales Growth Rate by Application (2020-2025)
Figure 38. Global NGS-based RNA-seq Sales Market Share by Region (2020-2025)
Figure 39. Global NGS-based RNA-seq Market Size by Region (2020-2025)
Figure 40. North America NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America NGS-based RNA-seq Sales Market Share by Country in 2024
Figure 43. North America NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America NGS-based RNA-seq Market Size by Country in 2024
Figure 45. U.S. NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada NGS-based RNA-seq Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada NGS-based RNA-seq Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico NGS-based RNA-seq Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico NGS-based RNA-seq Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe NGS-based RNA-seq Sales Market Share by Country in 2024
Figure 53. Europe NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe NGS-based RNA-seq Market Size by Country in 2024
Figure 55. Germany NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific NGS-based RNA-seq Sales and Growth Rate (K Units)
Figure 66. Asia Pacific NGS-based RNA-seq Sales Market Share by Region in 2024
Figure 67. Asia Pacific NGS-based RNA-seq Market Size by Region in 2024
Figure 68. China NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America NGS-based RNA-seq Sales and Growth Rate (K Units)
Figure 79. South America NGS-based RNA-seq Sales Market Share by Country in 2024
Figure 80. South America NGS-based RNA-seq Market Size and Growth Rate (M USD)
Figure 81. South America NGS-based RNA-seq Market Size by Country in 2024
Figure 82. Brazil NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa NGS-based RNA-seq Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa NGS-based RNA-seq Sales Market Share by Region in 2024
Figure 90. Middle East and Africa NGS-based RNA-seq Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa NGS-based RNA-seq Market Size by Region in 2024
Figure 92. Saudi Arabia NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global NGS-based RNA-seq Production Market Share by Region (2020-2025)
Figure 103. North America NGS-based RNA-seq Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe NGS-based RNA-seq Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan NGS-based RNA-seq Production (K Units) Growth Rate (2020-2025)
Figure 106. China NGS-based RNA-seq Production (K Units) Growth Rate (2020-2025)
Figure 107. Global NGS-based RNA-seq Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global NGS-based RNA-seq Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global NGS-based RNA-seq Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global NGS-based RNA-seq Market Share Forecast by Type (2026-2035)
Figure 111. Global NGS-based RNA-seq Sales Forecast by Application (2026-2035)
Figure 112. Global NGS-based RNA-seq Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of NGS-based RNA-seq
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global NGS-based RNA-seq Market Size (M USD), 2025-2035
Figure 5. Global NGS-based RNA-seq Market Size (M USD) (2020-2035)
Figure 6. Global NGS-based RNA-seq Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. NGS-based RNA-seq Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global NGS-based RNA-seq Product Life Cycle
Figure 13. NGS-based RNA-seq Sales Share by Manufacturers in 2025
Figure 14. Global NGS-based RNA-seq Revenue Share by Manufacturers in 2025
Figure 15. NGS-based RNA-seq Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market NGS-based RNA-seq Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by NGS-based RNA-seq Revenue in 2025
Figure 18. Industry Chain Map of NGS-based RNA-seq
Figure 19. Global NGS-based RNA-seq Market PEST Analysis
Figure 20. Global NGS-based RNA-seq Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global NGS-based RNA-seq Market Share by Type
Figure 27. Sales Market Share of NGS-based RNA-seq by Type (2020-2025)
Figure 28. Sales Market Share of NGS-based RNA-seq by Type in 2025
Figure 29. Market Share of NGS-based RNA-seq by Type (2020-2025)
Figure 30. Market Share of NGS-based RNA-seq by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global NGS-based RNA-seq Market Share by Application
Figure 33. Global NGS-based RNA-seq Sales Market Share by Application (2020-2025)
Figure 34. Global NGS-based RNA-seq Sales Market Share by Application in 2025
Figure 35. Global NGS-based RNA-seq Market Share by Application (2020-2025)
Figure 36. Global NGS-based RNA-seq Market Share by Application in 2025
Figure 37. Global NGS-based RNA-seq Sales Growth Rate by Application (2020-2025)
Figure 38. Global NGS-based RNA-seq Sales Market Share by Region (2020-2025)
Figure 39. Global NGS-based RNA-seq Market Size by Region (2020-2025)
Figure 40. North America NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America NGS-based RNA-seq Sales Market Share by Country in 2024
Figure 43. North America NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America NGS-based RNA-seq Market Size by Country in 2024
Figure 45. U.S. NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada NGS-based RNA-seq Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada NGS-based RNA-seq Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico NGS-based RNA-seq Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico NGS-based RNA-seq Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe NGS-based RNA-seq Sales Market Share by Country in 2024
Figure 53. Europe NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe NGS-based RNA-seq Market Size by Country in 2024
Figure 55. Germany NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific NGS-based RNA-seq Sales and Growth Rate (K Units)
Figure 66. Asia Pacific NGS-based RNA-seq Sales Market Share by Region in 2024
Figure 67. Asia Pacific NGS-based RNA-seq Market Size by Region in 2024
Figure 68. China NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America NGS-based RNA-seq Sales and Growth Rate (K Units)
Figure 79. South America NGS-based RNA-seq Sales Market Share by Country in 2024
Figure 80. South America NGS-based RNA-seq Market Size and Growth Rate (M USD)
Figure 81. South America NGS-based RNA-seq Market Size by Country in 2024
Figure 82. Brazil NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa NGS-based RNA-seq Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa NGS-based RNA-seq Sales Market Share by Region in 2024
Figure 90. Middle East and Africa NGS-based RNA-seq Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa NGS-based RNA-seq Market Size by Region in 2024
Figure 92. Saudi Arabia NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa NGS-based RNA-seq Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa NGS-based RNA-seq Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global NGS-based RNA-seq Production Market Share by Region (2020-2025)
Figure 103. North America NGS-based RNA-seq Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe NGS-based RNA-seq Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan NGS-based RNA-seq Production (K Units) Growth Rate (2020-2025)
Figure 106. China NGS-based RNA-seq Production (K Units) Growth Rate (2020-2025)
Figure 107. Global NGS-based RNA-seq Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global NGS-based RNA-seq Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global NGS-based RNA-seq Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global NGS-based RNA-seq Market Share Forecast by Type (2026-2035)
Figure 111. Global NGS-based RNA-seq Sales Forecast by Application (2026-2035)
Figure 112. Global NGS-based RNA-seq Market Share Forecast by Application (2026-2035)
